India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......
Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
The prevalent strain of COVID-19 is mild and the Serum Institute of India has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar......
IMAGE: Adar Poonawalla, CEO, Serum Institute of India. Photograph: ANI Photo With only 146 sites conducting vaccinations in India and a few hundred vaccine shots administered every day,......
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. IMAGE:......
SBI was the top loser in the Sensex pack, shedding over 1 per cent. ITC, NTPC, Tech Mahindra, Tata Steel, Kotak Bank and M&M were among major losers. Benchmark indices Sensex and Nifty retreated......
As many as 28 of its constituents closed with gains while two declined. The broad-based Nifty of the National Stock Exchange rose by 147.20 points or 0.86 per cent to settle 17,233.45, tracking......